Once‐daily LABA/ICS combined inhalers versus inhaled long‐acting beta2‐agonists for people with chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, February 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 15,621 followers.

RT @CochraneAirways: Once-daily LABA/ICS combined inhalers vs inhaled LABA for people with COPD protocol now published: https://t.co/Vjcjx…

RT @CochraneAirways: Once-daily LABA/ICS combined inhalers vs inhaled LABA for people with COPD protocol now published: https://t.co/Vjcjx…

RT @CochraneAirways: New protocol published: Once-daily LABA/ICS combined inhalers vs inhaled LABA for people with COPD: https://t.co/edcm…

New protocol published: Once-daily LABA/ICS combined inhalers vs inhaled LABA for people with COPD: https://t.co/edcmyYGmnY

Once-daily LABA/ICS combined inhalers vs inhaled LABA for people with COPD protocol now published: https://t.co/VjcjxES9qf